RAD51 and breast cancer: Kato et al. screened RAD51 for germline mutations in 45 Japanese high-risk breast cancer patients and reported a single missense variant, p.Arg150Gln, which was proposed to be the disease-causing mutation in two unrelated Japanese patients with bilateral breast cancer and with a familial history of the disease.